|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2004-1-21
|
|
pubmed:abstractText |
Butein is known to be the major component of the bark of Rhus verniciflua Stokes (Anacardiaceae). The aim of this work was to investigate the effects of butein on liver fibrosis induced by carbon tetrachloride (CCl4) in rats, and to explore its antifibrogenic mechanism. Butein (10 mg/kg/day or 25 mg/kg/day) showed a significant reduction of hydroxyproline and malondialdehyde levels in rats. The expression of alpha1(I) collagen and tissue inhibitor of metalloproteinase-1 (TIMP-1) mRNAs in liver was clearly reduced in a dose-dependent manner in rats given butein compared with control CCl4-treated rats. These data suggest the potential of butein to serve as an antifibrogenic agent by inhibition of collagen accumulation and lipid peroxidation, and by down-regulation of the expression of both alpha1(I) collagen and TIMP-1 mRNA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carbon Tetrachloride,
http://linkedlifedata.com/resource/pubmed/chemical/Chalcone,
http://linkedlifedata.com/resource/pubmed/chemical/Chalcones,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Plant Extracts,
http://linkedlifedata.com/resource/pubmed/chemical/Protective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of...,
http://linkedlifedata.com/resource/pubmed/chemical/butein
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0032-0943
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
990-4
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14735434-Animals,
pubmed-meshheading:14735434-Carbon Tetrachloride,
pubmed-meshheading:14735434-Chalcone,
pubmed-meshheading:14735434-Chalcones,
pubmed-meshheading:14735434-Collagen Type I,
pubmed-meshheading:14735434-DNA Primers,
pubmed-meshheading:14735434-Dose-Response Relationship, Drug,
pubmed-meshheading:14735434-Liver Cirrhosis, Experimental,
pubmed-meshheading:14735434-Male,
pubmed-meshheading:14735434-Phytotherapy,
pubmed-meshheading:14735434-Plant Bark,
pubmed-meshheading:14735434-Plant Extracts,
pubmed-meshheading:14735434-Protective Agents,
pubmed-meshheading:14735434-RNA, Messenger,
pubmed-meshheading:14735434-Rats,
pubmed-meshheading:14735434-Rats, Sprague-Dawley,
pubmed-meshheading:14735434-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:14735434-Rhus,
pubmed-meshheading:14735434-Tissue Inhibitor of Metalloproteinase-1
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The chalcone butein from Rhus verniciflua shows antifibrogenic activity.
|
|
pubmed:affiliation |
College of Pharmacy, Medicinal Resources Research Center, Wonkwang University, Iksan, Chonbuk, Republic of Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
